Patents by Inventor Amit Kesarwani
Amit Kesarwani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10772879Abstract: This invention relates to pharmaceutical formulations comprising 1-(2-thien-2?-yl-2-oxo-ethyl)-3-(methanesulfonyl hydrazine carbonyl) pyridinium, its pharmaceutically acceptable salts, salt-cocrystals and co-crystals, particularly 1-(2-thien-2?-yl-2-oxo-ethyl)-3-5(methanesulfonyl hydrazine carbonyl) pyridinium chloride. The formulations are suitable for oral administration and also comprise a permeability enhancer or a suitable base or a mixture thereof. The formulations of this invention are for treating diseases associated with advanced glycation end products.Type: GrantFiled: April 5, 2016Date of Patent: September 15, 2020Assignee: Torrent Pharmaceuticals LimitedInventors: Chaitanya Dutt, Jaya Abraham, Vivek Mishra, Amit Kesarwani, Ramesh Chandra Gupta, Shailesh Deshpande, Shital Kumar Zambad, Anoop Mathur, Jignesh Kotecha, Sachin Latad, Manish Patel, Anita Chaudhari
-
Patent number: 10717727Abstract: The present invention relates to novel pyridinium compounds, their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the above mentioned compounds for the preparation of medicament for use as pharmaceuticals.Type: GrantFiled: February 4, 2019Date of Patent: July 21, 2020Assignee: Torrent Pharmaceuticals LimitedInventors: Chaitanya Dutt, Rameshchandra Gupta, Manish Patel, Jaya Abraham, Vivek Mishra, Amit Kesarwani, Shailesh Deshpande, Shital Kumar Zambad, Anoop Mathur, Jignesh Kotecha, Sachin Latad, Anita Chaudhari
-
Publication number: 20190169175Abstract: The present invention relates to novel pyridinium compounds, their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the above mentioned compounds for the preparation of medicament for use as pharmaceuticals.Type: ApplicationFiled: February 4, 2019Publication date: June 6, 2019Applicant: TORRENT PHARMACEUTICALS LIMITEDInventors: Chaitanya DUTT, Rameshchandra GUPTA, Manish PATEL, Jaya ABRAHAM, Vivek MISHRA, Amit KESARWANI, Shailesh DESHPANDE, Shital Kumar ZAMBAD, Anoop MATHUR, Jignesh KOTECHA, Sachin LATAD, Anita CHAUDHARI
-
Patent number: 10233175Abstract: The present invention relates to novel pyridinium compounds, their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the above mentioned compounds for the preparation of medicament for use as pharmaceuticals.Type: GrantFiled: April 5, 2016Date of Patent: March 19, 2019Assignee: Torrent Pharmaceuticals LimitedInventors: Chaitanya Dutt, Rameshchandra Gupta, Manish Patel, Jaya Abraham, Vivek Mishra, Amit Kesarwani, Shailesh Deshpande, Shital Kumar Zambad, Anoop Mathur, Jignesh Kotecha, Sachin Latad, Anita Chaudhari
-
Publication number: 20180118728Abstract: The present invention relates to novel pyridinium compounds, their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the above mentioned compounds for the preparation of medicament for use as pharmaceuticals.Type: ApplicationFiled: April 5, 2016Publication date: May 3, 2018Applicant: TORRENT PHARMACEUTICALS LIMITEDInventors: Chaitanya DUTT, Rameshchandra GUPTA, Manish PATEL, Jaya ABRAHAM, Vivek MISHRA, Amit KESARWANI, Shailesh DESHPANDE, Shital Kumar ZAMBAD, Anoop MATHUR, Jignesh KOTECHA, Sachin LATAD, Anita CHAUDHARI
-
Publication number: 20180110763Abstract: This invention relates to pharmaceutical formulations comprising 1-(2-thien-2?-yl-2-oxo-ethyl)-3-(methanesulfonyl hydrazine carbonyl) pyridinium, its pharmaceutically acceptable salts, salt-cocrystals and co-crystals, particularly 1-(2-thien-2?-yl-2-oxo-ethyl)-3-5(methanesulfonyl hydrazine carbonyl) pyridinium chloride. The formulations are suitable for oral administration and also comprise a permeability enhancer or a suitable base or a mixture thereof.Type: ApplicationFiled: April 5, 2016Publication date: April 26, 2018Applicant: TORRENT PHARMACEUTICALS LIMITEDInventors: Chaitanya DUTT, Jaya ABRAHAM, Vivek MISHRA, Amit KESARWANI, Ramesh Chandra GUPTA, Shailesh DESHPANDE, Shital Kumar ZAMBAD, Anoop MATHUR, Jignesh KOTECHA, Sachin LATAD, Manish PATEL, Anita CHAUDHARI
-
Patent number: 9364518Abstract: The present invention provides a pharmaceutical composition capable of forming in-situ implant comprising goserelin or its pharmaceutically acceptable salts thereof, biodegradable polymer and a biocompatible organic solvent wherein the biocompatible organic solvent is miscible to dispersible in aqueous medium or body fluid. The present invention further provides a process for the preparation of pharmaceutical composition capable of forming in-situ implant. A kit containing composition for in-situ implant is provided comprising a first vial comprising a composition comprising a biodegradable polymer and a biocompatible organic solvent; wherein the biocompatible organic solvent is miscible to dispersible in aqueous medium or body fluid; and a second vial comprising goserelin acetate.Type: GrantFiled: June 24, 2011Date of Patent: June 14, 2016Assignee: Torrent Pharmaceuticals LimitedInventors: Sunil S. Nadkarni, Jaya Abraham, Amit Kesarwani, Astha Parmar
-
Publication number: 20130157951Abstract: The present invention provides a pharmaceutical composition capable of forming in-situ implant comprising goserelin or its pharmaceutically acceptable salts thereof, biodegradable polymer and a biocompatible organic solvent wherein the biocompatible organic solvent is miscible to dispersible in aqueous medium or body fluid. The present invention further provides a process for the preparation of pharmaceutical composition capable of forming in-situ implant. A kit containing composition for in-situ implant is provided comprising a first vial comprising a composition comprising a biodegradable polymer and a biocompatible organic solvent; wherein the biocompatible organic solvent is miscible to dispersible in aqueous medium or body fluid; and a second vial comprising goserelin acetate.Type: ApplicationFiled: June 24, 2011Publication date: June 20, 2013Applicant: Torrent Pharmaceuticals LimitedInventors: Sunil S. Nadkarni, Jaya Abraham, Amit Kesarwani, Astha Parmar
-
Publication number: 20110302625Abstract: A system for managing and controlling data. The system includes provisions for easily and rapidly updating and managing a computer system, particularly a complex computer system in which several computers communicate with one another. The system also includes a central database which plays a key role in the management and control of the computer system. Most of the management functions are retained in the central database and remote offices, which generally do not retain data management information, communicate with the central office to retrieve data management information. The system also includes a novel approach to manipulating data.Type: ApplicationFiled: August 15, 2011Publication date: December 8, 2011Inventors: Amit Kesarwani, Amy Rich Warner
-
Patent number: 8006286Abstract: A system for managing and controlling data. The system includes provisions for easily and rapidly updating and managing a computer system, particularly a complex computer system in which several computers communicate with one another. The system also includes a central database which plays a key role in the management and control of the computer system. Most of the management functions are retained in the central database and remote offices, which generally do not retain data management information, communicate with the central office to retrieve data management information. The system also includes a novel approach to manipulating data.Type: GrantFiled: April 17, 2007Date of Patent: August 23, 2011Assignee: AT&T Intellectual Property I, LPInventors: Amit Kesarwani, Amy Rich Warner
-
Publication number: 20070286182Abstract: A system for managing and controlling data. The system includes provisions for easily and rapidly updating and managing a computer system, particularly a complex computer system in which several computers communicate with one another. The system also includes a central database which plays a key role in the management and control of the computer system. Most of the management functions are retained in the central database and remote offices, which generally do not retain data management information, communicate with the central office to retrieve data management information. The system also includes a novel approach to manipulating data.Type: ApplicationFiled: April 17, 2007Publication date: December 13, 2007Inventors: Amit Kesarwani, Amy Warner
-
Patent number: 7213258Abstract: A system for managing and controlling data. The system includes provisions for easily and rapidly updating and managing a computer system, particularly a complex computer system in which several computers communicate with one another. The system also includes a central database which plays a key role in the management and control of the computer system. Most of the management functions are retained in the central database and remote offices, which generally do not retain data management information, communicate with the central office to retrieve data management information. The system also includes a novel approach to manipulating data.Type: GrantFiled: December 21, 1999Date of Patent: May 1, 2007Assignee: BellSouth Intellectual Property Corp.Inventors: Amit Kesarwani, Amy Rich Warner
-
Publication number: 20070071819Abstract: The present invention relates to multiple-unit modified release carbamazepine compositions for oral administration which include: (i) at least one extended release unit, and (ii) at least one enteric release unit. Also provided are processes for the preparation of multiple-unit modified release compositions of carbamazepine.Type: ApplicationFiled: May 30, 2006Publication date: March 29, 2007Inventors: Amit Kesarwani, Manish Chawla, Rajeev Raghuvanshi, Ashok Rampal